AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents

Green, Steven ; Parkin, Brian ; Lai, Catherine ; Gojo, Ivana ; Zeidner, Joshua

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S284-S284 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível